MITOCHONDRIAL COMPLEX I DEFICIENCY IN PARKINSON'S DISEASE
- 1 June 1989
- journal article
- letter
- Published by Elsevier in The Lancet
- Vol. 333 (8649), 1269
- https://doi.org/10.1016/s0140-6736(89)92366-0
Abstract
No abstract availableThis publication has 6 references indexed in Scilit:
- Normal oxidative damage to mitochondrial and nuclear DNA is extensive.Proceedings of the National Academy of Sciences, 1988
- A Dopaminergic Cell Line Variant Resistant to the Neurotoxin 1‐Methyl‐4‐Phenyl‐1,2,3,6‐TetrahydropyridineJournal of Neurochemistry, 1987
- Photolabelling of a mitochondrially encoded subunit of NADH dehydrogenase with [3H]dihydrorotenoneFEBS Letters, 1987
- Dopaminergic toxicity of rotenone and the 1-methyl-4-phenylpyridinium ion after their stereotaxic administration to rats: Implication for the mechanism of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine toxicityNeuroscience Letters, 1985
- Parkinsonism-inducing neurotoxin, N-methyl-4-phenyl-1,2,3,6 -tetrahydropyridine: uptake of the metabolite N-methyl-4-phenylpyridine by dopamine neurons explains selective toxicity.Proceedings of the National Academy of Sciences, 1985
- Repair of pyrimidine dimers in nuclear and mitochondrial DNA of yeast irradiated with low doses of ultraviolet lightJournal of Molecular Biology, 1975